Delivery Order SPE2DB20D7061-SPE2DB25FSPW5
- Not listed
- The Defense Logistics Agency awarded a $1,459.36 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (90-count packages). This firm fixed-price delivery order, with a completion date of September 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120-count) with a ceiling value of $2,608.99. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is set for ultimate completion by August 7, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120-count) with a ceiling value of $4,953.94. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120-count units) valued at $1,240.25. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to the prime contractor. The order is scheduled for completion by July 29, 2025, with performance to be executed from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets (120 count) with a ceiling value of $1,234.86 under a firm fixed price contract type. The award, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, was competitively awarded with no set-aside designation. Performance of this delivery order will be executed from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Alfuzosin HCL ER 10 mg tablets (1,000 count) valued at $2,355.30 under a firm fixed-price contract type. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025, and represents a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (90-count) with a ceiling value of $3,894.90. This competitive award, with no set-aside designation, is issued under a firm fixed-price delivery order contract type and is scheduled for completion by September 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (90-count units) with a ceiling value of $1,541.01. This is a firm fixed-price delivery order with no set-aside designation, completed competitively under open procurement requirements. The contract calls for delivery to Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120 count) with a ceiling value of $2,765.95. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (90-count units) with a ceiling value of $2,770.72. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB25FSPW5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Alfuzosin HCL ER 10 mg tablets (120-count units) with a contract ceiling value of $3,174.90 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively procured with no set-aside designation, and performance is scheduled for completion by September 19, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency and military healthcare systems. The company's comprehensive pharmaceutical supply portfolio under the DLA contract vehicle includes brand-name and generic medications, vaccines, and specialized medical supplies spanning multiple therapeutic domains. This delivery order for Alfuzosin HCL ER, a medication used to treat benign prostatic hyperplasia, exemplifies the routine high-volume pharmaceutical deliveries the contractor fulfills to support military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/18/25 |